AD01 Follow up Extension Visit

Observational Follow-up Extension Study-visit to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS001 in Patients With Alzheimer's Disease

NCT01225809•Affiris AG

View on ClinicalTrials.gov

Summary

Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Written informed consent signed and dated by the patient or the patient's legal representative and the caregiver.
•Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination with AFFITOPE AD01
•Availability of a partner/caregiver knowing the patient

Exclusion Criteria

•Patients having received no vaccination with AFFITOPE AD01
•History of questionable compliance to visit schedule

Locations (1)

Univ. Klinik für Neurologie

Vienna, Austria

Key Dates

Start Date

September 1, 2010

Primary Completion Date

December 1, 2010

Completion Date

January 1, 2011

Last Updated

January 26, 2011

Enrollment

ACTUAL participants

Conditions

Alzheimer´s Disease

Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia

NCT02224326

Alzheimer´s Disease

View study

UNKNOWN

EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors

NCT02623764

Alzheimer´s Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2011Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions